Absci Corp (ABSI)
Healthcare
Biotechnology
7.90 $
+1.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Absci Corp (ABSI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -26 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -19 | -10 | -15 | -18 | -17 | -21 | -17 | -22 | -17 | -25 | -29 | -26 | -97 | |
| 3.5 | 3.5 | 3.5 | 3.4 | 3.4 | 3.4 | 3.2 | 3.1 | 3.0 | 2.8 | 2.8 | 2.7 | 11 | |
| 3.0 | 2.5 | 3.2 | 3.6 | 5.3 | 5.5 | 5.1 | 4.9 | 4.8 | 4.4 | 4.3 | 4.4 | 18 | |
| 24 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -4.3 | 6.1 | 1.5 | -2.2 | 0.4 | -2.4 | 3.8 | -2.8 | 6.7 | -2.7 | -0.8 | -3.1 | 0.1 | |
| 0.3 | 0.3 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.2 | 1.0 | 0.1 | 0.0 | 1.3 | |
| 70 | 20 | 19 | -77 | 1.3 | 15 | 19 | -15 | 9.0 | -64 | 20 | 7.4 | -28 | |
| 0.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.7 | – | – | – | – | -0.9 | -1.0 | -0.8 | -1.1 | -0.8 | -0.5 | -0.5 | -2.8 | |
| -1.2 | -0.9 | -1.2 | 81 | -0.1 | 0.5 | 1.0 | 43 | -1.0 | 60 | 3.8 | 7.6 | 71 | |
| 50 | 8.9 | 2.8 | -13 | -16 | -5.5 | 3.1 | 5.9 | -8.8 | -28 | -5.8 | -11 | -54 | |
| -19 | -11 | -15 | -18 | -17 | -21 | -17 | -22 | -17 | -26 | -29 | -26 | -99 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.